Advertisement

Calcified Tissue International

, Volume 104, Issue 1, pp 59–69 | Cite as

Metformin Alleviates the Bone Loss Induced by Ketogenic Diet: An In Vivo Study in Mice

  • Qi Liu
  • Xiaolin Xu
  • Zhou Yang
  • Yapu Liu
  • Xiuhua Wu
  • Zhiping Huang
  • Junhao Liu
  • Zucheng Huang
  • Ganggang Kong
  • Jianyang Ding
  • Rong Li
  • Junyu Lin
  • Qingan ZhuEmail author
Original Research
  • 211 Downloads

Abstract

Metformin (Met), an anti-diabetes drug, has also shown therapeutic effects for ovariectomy-induced (OVX) osteoporosis. However, similar effects against bone loss induced by a ketogenic diet (KD) have not been tested. This study was aimed to evaluate the microarchitectures and biomechanics of KD-induced osteoporosis with and without administration of Met, and compare the effect of Met on bone loss induced by KD with OVX. Forty female C57BL/6J mice were randomly divided into Sham, OVX, OVX + Met (100 mg/kg/day), KD (3:1 ratio of fat to carbohydrate and protein), and KD + Met (100 mg/kg/day) groups. After 12 weeks, the bone mass and biomechanics were measured in distal cancellous bone and in mid-shaft cortical bone of the femur. The activities of serum alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP), together with immunohistochemistry staining of osteocalcin (OCN) and TRAP, were evaluated. Both OVX and KD induced significant bone loss and compromised biomechanical properties in the cancellous bone, but no effect was found in cortical bone. The administration of Met increased the cancellous bone volume fraction (BV/TV) from 3.78 to 5.23% following the OVX and from 4.04 to 6.33% following the KD, it also enhanced the compressive stiffness from 47 to 160 N/mm following the OVX and from 35 to 340 N/mm with the KD. Met effectively increased serum ALP in the KD group while decreased serum TRAP in the OVX group, but up-regulated expression of OCN and down-regulated expression of TRAP in both OVX and KD groups. The present study demonstrated that Met effectively attenuated the cancellous bone loss induced by KD and maintained the biomechanical properties of long bones, providing evidence for Met as a treatment of by KD-induced osteoporosis in teenage skeleton.

Keywords

Metformin Osteoporosis Ovariectomy Ketogenic diet Bone loss Micro-CT 

Notes

Acknowledgements

This study was supported by Guangdong Province Natural Science Foundation of China (No. 2015A030313276) and Dean Foundation of Nanfang Hospital (No. 2016Z021).

Author Contributions

QZ and QL designed the experiments. QL, ZY, and XX conducted the animal experiments. QL, ZY, JL, and YL collected the samples. QL, YZ, XX, XW and ZH measured and collected the data. ZH, GK, JD, RL and JL completed the data analysis. QL wrote the manuscript, and XX and QZ revised the manuscript.

Compliance with Ethical Standards

Conflict of interest

Qi Liu, Xiaolin Xu, Zhou Yang, Yapu Liu, Xiuhua Wu, Zhiping Huang, Junhao Liu, Zucheng Huang, Ganggang Kong, Jianyang Ding, Rong Li, Junyu Lin, and Qingan Zhu declare no conflicts of interest.

Human and Animal Rights and Informed Consent

The present study was approved by the Animal Experiments Ethics Committee of Southern Medical University. The animal procedures were conducted in accordance with the Guidelines of Caring for Laboratory Animals by the Ministry of Science and Technology of the People’s Republic of China. Surgery was performed under anesthesia, and all efforts were made to minimize suffering.

References

  1. 1.
    Kossoff EH, Zupec-Kania BA, Rho JM (2009) Ketogenic diets: an update for child neurologists. J Child Neurol 24:979–988CrossRefGoogle Scholar
  2. 2.
    Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3:59CrossRefGoogle Scholar
  3. 3.
    Paoli A, Rubini A, Volek JS, Grimaldi KA (2013) Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr 67:789–796CrossRefGoogle Scholar
  4. 4.
    Wang X, Wu X, Liu Q, Kong G, Zhou J, Jiang J, Wu X, Huang Z, Su W, Zhu Q (2017) Ketogenic metabolism inhibits histone deacetylase (HDAC) and reduces oxidative stress after spinal cord injury in rats. Neuroscience 366:36–43CrossRefGoogle Scholar
  5. 5.
    Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, Huang Z, Li R, Zhu Q (2017) The ketone metabolite beta-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases. J Neurotrauma 34:2645–2655CrossRefGoogle Scholar
  6. 6.
    Hahn TJ, Halstead LR, DeVivo DC (1979) Disordered mineral metabolism produced by ketogenic diet therapy. Calcif Tissue Int 28:17–22CrossRefGoogle Scholar
  7. 7.
    Bergqvist AG, Schall JI, Stallings VA, Zemel BS (2008) Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 88:1678–1684CrossRefGoogle Scholar
  8. 8.
    Bielohuby M, Matsuura M, Herbach N, Kienzle E, Slawik M, Hoeflich A, Bidlingmaier M (2010) Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats. J Bone Miner Res 25:275–284CrossRefGoogle Scholar
  9. 9.
    Wu X, Huang Z, Wang X, Fu Z, Liu J, Huang Z, Kong G, Xu X, Ding J, Zhu Q (2017) Ketogenic diet compromises both cancellous and cortical bone mass in mice. Calcif Tissue Int 101:412–421CrossRefGoogle Scholar
  10. 10.
    Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S (2016) Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 164:740–751CrossRefGoogle Scholar
  11. 11.
    Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299CrossRefGoogle Scholar
  12. 12.
    Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T (2008) Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun 375:414–419CrossRefGoogle Scholar
  13. 13.
    Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L (2006) Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 536:38–46CrossRefGoogle Scholar
  14. 14.
    Zhen D, Chen Y, Tang X (2010) Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications 24:334–344CrossRefGoogle Scholar
  15. 15.
    Gao Y, Li Y, Xue J, Jia Y, Hu J (2010) Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats. Eur J Pharmacol 635:231–236CrossRefGoogle Scholar
  16. 16.
    Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD, Bai XC (2011) Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem 112:2902–2909CrossRefGoogle Scholar
  17. 17.
    Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S–841SCrossRefGoogle Scholar
  18. 18.
    Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468–1486CrossRefGoogle Scholar
  19. 19.
    Arias-Moreno AJ, Ito K, van Rietbergen B (2016) Micro-Finite Element analysis will overestimate the compressive stiffness of fractured cancellous bone. J Biomech 49:2613–2618CrossRefGoogle Scholar
  20. 20.
    Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–191CrossRefGoogle Scholar
  21. 21.
    Qi S, Zheng H (2017) Combined effects of phytoestrogen genistein and silicon on ovariectomy-induced bone loss in rat. Biol Trace Elem Res 177:281–287CrossRefGoogle Scholar
  22. 22.
    Unsal F, Sonmez MF (2014) The effects of ovariectomy on ghrelin expression in the rat uterus. Adv Clin Exp Med 23:363–370CrossRefGoogle Scholar
  23. 23.
    Li M, Shen Y, Wronski TJ (1997) Time course of femoral neck osteopenia in ovariectomized rats. Bone 20:55–61CrossRefGoogle Scholar
  24. 24.
    Danielsen CC, Mosekilde L, Svenstrup B (1993) Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int 52:26–33CrossRefGoogle Scholar
  25. 25.
    Sasaki H, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Kamo K, Shimada Y (2010) Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice. J Bone Miner Metab 28:403–409CrossRefGoogle Scholar
  26. 26.
    Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88–91CrossRefGoogle Scholar
  27. 27.
    Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RJ, de Cabo R, Ulrich S, Akassoglou K, Verdin E (2013) Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211–214CrossRefGoogle Scholar
  28. 28.
    Wang X, Liu Q, Zhou J, Wu X, Zhu Q (2017) β Hydroxybutyrate levels in serum and cerebrospinal fluid under ketone body metabolism in rats. Exp Anim 66:177–182CrossRefGoogle Scholar
  29. 29.
    Frommelt L, Bielohuby M, Stoehr BJ, Menhofer D, Bidlingmaier M, Kienzle E (2014) Effects of low-carbohydrate, high-fat diets on apparent digestibility of minerals and trace elements in rats. Nutrition 30:869–875CrossRefGoogle Scholar
  30. 30.
    Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P (2013) Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease. Discov Med 16:277–286Google Scholar
  31. 31.
    Cabreiro F, Au C, Leung KY, Vergara-Irigaray N, Cocheme HM, Noori T, Weinkove D, Schuster E, Greene ND, Gems D (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153:228–239CrossRefGoogle Scholar
  32. 32.
    Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ (2010) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322–326CrossRefGoogle Scholar
  33. 33.
    Chandra A, Lin T, Tribble MB, Zhu J, Altman AR, Tseng WJ, Zhang Y, Akintoye SO, Cengel K, Liu XS, Qin L (2014) PTH1-34 alleviates radiotherapy-induced local bone loss by improving osteoblast and osteocyte survival. Bone 67:33–40CrossRefGoogle Scholar
  34. 34.
    Raisz LG (1999) Physiology and pathophysiology of bone remodeling. Clin Chem 45:1353–1358Google Scholar
  35. 35.
    Bahlous A, Kalai E, Hadj SM, Bouzid K, Zerelli L (2006) Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis. Tunis Med 84:751–757Google Scholar
  36. 36.
    Hwang YH, Son YJ, Paik MJ, Yee ST (2017) Effects of diisononyl phthalate on osteopenia in intact mice. Toxicol Appl Pharmacol 334:120–128CrossRefGoogle Scholar
  37. 37.
    Greenblatt MB, Tsai JN, Wein MN (2017) Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem 63:464–474CrossRefGoogle Scholar
  38. 38.
    Lin S, Huang J, Fu Z, Liang Y, Wu H, Xu L, Sun Y, Lee WY, Wu T, Qin L, Cui L, Li G (2015) The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats. Calcif Tissue Int 96:541–551CrossRefGoogle Scholar
  39. 39.
    Zhao Y, Zou B, Shi Z, Wu Q, Chen GQ (2007) The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats. Biomaterials 28:3063–3073CrossRefGoogle Scholar
  40. 40.
    Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595–608CrossRefGoogle Scholar
  41. 41.
    Komori T (2015) Animal models for osteoporosis. Eur J Pharmacol 759:287–294CrossRefGoogle Scholar
  42. 42.
    Comelekoglu U, Mutlu H, Yalin S, Bagis S, Yildiz A, Ogenler O (2007) Determining the biomechanical quality of normal and osteoporotic bones in rat femora through biomechanical test and finite element analysis. Acta Orthop Traumatol Turc 41:53–57Google Scholar
  43. 43.
    van Eijden TM, van Ruijven LJ, Giesen EB (2004) Bone tissue stiffness in the mandibular condyle is dependent on the direction and density of the cancellous structure. Calcif Tissue Int 75:502–508CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Qi Liu
    • 1
  • Xiaolin Xu
    • 1
  • Zhou Yang
    • 1
  • Yapu Liu
    • 1
    • 2
  • Xiuhua Wu
    • 1
  • Zhiping Huang
    • 1
  • Junhao Liu
    • 1
  • Zucheng Huang
    • 1
  • Ganggang Kong
    • 1
  • Jianyang Ding
    • 1
  • Rong Li
    • 1
  • Junyu Lin
    • 1
  • Qingan Zhu
    • 1
    Email author
  1. 1.Department of Spinal Surgery, Nanfang HospitalSouthern Medical UniversityGuangzhouChina
  2. 2.Department of Spinal SurgeryThe Second Affiliated Hospital of Luohe Medical CollegeLuoheChina

Personalised recommendations